Insulin-stimulated glycogenesis and insulin degradation were studied simultaneously at 370C in cultured foetal hepatocytes grown for 2-3 days in the presence of cortisol. Degradation of cell-associated insulin, as measured by trichloroacetic acid precipitation, was significant after 4 min in the presence of 1-3 nM-'25I-labelled insulin. This process became maximal (30% of insulin degraded) after 20min, a time when binding-state conditions were achieved. No insulin-degradative activity was detected in a medium that had been exposed to cells. At steady-state, the appearance of insulin degradation products in the medium was linearly dependent on time (1.5 fmol/min per 106 cells at lnM-125I-labelled insulin). Chloroquine (3-504uM), bacitracin (0.1-10mM) and NH4Cl (1-10mM) inhibited insulin degradation as soon as this became detectable and caused an increase in the association of insulin to hepatocytes after 20min. Lidocaine and dansylcadaverine had similar effects, whereas N-ethylmaleimide, aprotinin, phenylmethanesulphonyl fluoride and leupeptin were found to be ineffective. Chloroquine, and also bacitracin, at concentrations that inhibited insulin degradation, decreased the insulin-stimulated incorporation of [14C]glucose into glycogen over 2h.
It is now well established that, on interaction with its receptors in target cells, insulin is internalized and ultimately associates with lysosomes. Although the main function of this process is to mediate the degradation of the hormone and possibly also the removal of its receptors from the cell surface, it has been proposed that insulin internalization and/or degradation might be required for biological action (Steiner, 1977) . The functional relationship between the degradation and short-term biological effects of insulin in adipocytes had been examined in the presence of the lysosomotropic agent chloroquine. These experiments indicated that insulin degradation was not a prerequisite for biological action (Suzuki & Kono, 1979; Hammons & Jarett, 1980; Marshall & Olefsky, 1980) . Cultured foetal hepatocytes have been shown to bind insulin specifically and to respond to the presence of the hormone by an enhanced ability to synthesize glycogen (Plas et aL, 1979 ; Menuelle & Plas, 1981) . In the present study, the degradation of insulin by these cells was characterized and found to Vol. 202 be exclusively receptor-mediated. This culture system was also used to examine the effects of chloroquine and other drugs that inhibit the cellular processing of receptor-bound ligands on the binding, degradation and biological action of insulin. The results suggest that insulin's action, and its degradation, may be functionally related in foetal hepatocytes.
were specified previously (Plas & Nunez, 1976; Rouer et al., 1980) .
Culture procedure
Primary cultures of hepatocytes were obtained from 17-and 18-day rat foetuses (Sprague-Dawley) as described previously (Plas et al., 1973) . Briefly, after mild trypsin treatment, the isolated cells were plated on a collagen substratum to which only the hepatocytes adhered, and after 18h the nonadhering haematopoietic cells were removed. At this step, the culture medium (2ml/dish) was replaced. This culture medium consisted of NCTC 109 medium (Evans et al., 1964) supplemented with 10% (v/v) foetal-calf serum, 10,uM-cortisol and 10mM-Hepes [4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid], pH 7.3. Then it was supplemented daily with glucose (0.5 mg/dish). All the experiments were performed after 2 or 3 days of culture in the presence of cortisol, when the glycogenic effect of insulin is fully expressed (Plas & Nunez, 1976 ).
Insulin binding and degradation studies
Pig insulin was labelled with 1251 at a specific radioactivity of 130-170Ci/g by a modification (Desbuquois et al., 1974) of the chloramine-T method. Incubations of 125I-labelled insulin (1-3 nM) with hepatocytes (about 1.3 x 106 cells/dish) were performed at 370C and pH7.3, in 2ml of culture medium. On completion of the incubation, the medium was removed and the cells were washed with 4 x 2.5 ml of ice-cold Hanks solution. This washing step was performed within 12 s. The cell-associated radioactivity was then extracted at 40C by three successive additions each of 0.5 ml of 8.5 M-acetic acid containing 0.35 mM-bacitracin. Unless otherwise stated, the recovery of radioactivity in the extract was about 95-98%; this value did not differ significantly from that observed when 0.1% (w/v) Triton X-100 containing 3M-acetic acid and 6 M-urea was used in the extraction procedure of Terris & Steiner (1975) (Table 1 ). The small amount of radioactivity remaining was solubilized with 0.7ml of 0.5M-NaOH for 30min at 750C. Corrections were made for the non-specific association of 125I-labelled insulin to cells by performing parallel incubations in the presence of native insulin (3,uM).
The labelled material recovered from the cells was allowed to dry at 230C in a vacuum desiccator containing solid NaOH. The residue was dissolved in 1 ml of 0.1 M-HCI and the solution was neutralized with 1 mM-Tris. This material was then tested for its ability to be precipitated by 5% (w/v) trichloroacetic acid and to bind specifically to rat liver membranes by the technique detailed previously (Desbuquois et al., 1974) . The extract was also subjected to gel filtration on Sephadex G-75 equilibrated with 5 M-acetic acid, and the labelled material, which was co-eluted with iodotyrosines, was characterized by paper chromatography (Rouer et al., 1980) . It was verified that the extraction procedure did not modify the behaviour of I251-labelled insulin for the three parameters mentioned above.
Glycogenesis studies
Glycogen labelling in the presence of [U-'4C1-glucose was determined as described previously (Plas et al., 1973 Table 1 . Characterization ofcell-associated radioactivity in hepatocytes incubated with 125I-labelled insulin Hepatocytes were incubated with 1 nM-'251I-labelled insulin for 45 min at 370C, in the presence or absence of 46,Mchloroquine. Then the cell-associated radioactivity was extracted and characterized by two methods as follows. (1) Radioactive material was solubilized with 8.5 M-acetic acid and the extracts were analysed by gel filtration on Sephadex G-75 and precipitation by trichloroacetic acid as described in the Materials and methods section. (2) Radioactive material was solubilized with 0.1% (w/v) Triton X-100 containing 3M-acetic acid and 6M-urea and applied to a column of Sephadex G-50 equilibrated with a solution containing 1 M-acetic acid, 6M-urea and 0.15 MNaCl, as described by Terris & Steiner (1975) . Peak I represents the material eluted in the void volume; peak II, intact '25I-labelled insulin, peak III, degradation products at the elution position of iodinated tyrosines. Each culture represents 1 .1 x 106 cells in 2 ml of medium. (Plas & Nunez, 1976 
Results
Characteristics of insulin binding, insulin degradation and insulin-stimulated glycogenesis Hepatocytes were incubated with 1 nM-'251-labelled insulin, a submaximal concentration for the glycogenic response (Plas et al., 1979) , and the cell-associated radioactivity was extracted, quantified and characterized after various intervals. The association of 125I-labelled insulin to cells occurred rapidly; binding steady-state was reached by 10min and persisted for at least 3h. At the steady-state, approx. 15 fmol of insulin/culture was bound. In the initial 4min, this cell-associated radioactivity could not be distinguished from intact insulin (trichloroacetic acid precipitation and rebinding technique analysis). With time, the cell-associated insulin gradually lost integrity and by 20min, degradation reached a steady-state and remained so for several hours. At the steady-state, 25-30% of the bound hormone was altered when examined by trichloroacetic acid precipitation, and 35% had lost its capacity to bind to liver membranes (Fig. 1) . On gel filtration, 75-80% of the radioactivity was recovered as intact insulin; most of the remaining radioactivity was present as low-molecular-weight material and was co-eluted with monoiodotyrosine. A small amount (1-2%) of radioactive material was also present in the void volume of the column (Table 1) . The elution profile of the radioactivity was identical with that obtained when gel filtration was performed on Sephadex G-50 equilibrated with the urea/acetic acid/NaCl mixture as described by Terris & Steiner (1975 
Effects ofchloroquine on the degradation ofcell-associated and medium insulin
At day 2 of the culture, 1 nM-'25I-labelled insulin (2pmol) was introduced in 2 ml of medium, and at the times indicated in the Table total binding and degradation of both cell-associated and medium insulin were determined. When tested, chloroquine was added at the same time as 125I-labelled insulin. Also 1 nM-'251-labelled insulin was added to 2 ml of medium in which hepatocytes had been grown for 30h, but in the absence of cells (*)* The fraction of the cell-associated radioactivity extracted by 8.5 M-acetic acid was 98% in the absence of chloroquine, whereas it was respectively 88, 79 and 76% after 2, 4 and 6 h of chloroquine presence. (Plas et al., 1979 (Table 3) . At the highest concentrations tested, these agents inhibited insulin degradation by 80-90%, and enhanced total binding by 30% (tests performed after 20min of insulin and drug presence). A 50% inhibition was obtained with about 10 uM-chloroquine, 1-2 mM-bacitracin and 3-10-mM NH4Cl. The concentrations required for half-maximal effects on binding were similar. In parallel experiments, leupeptin, N-ethylmaleimide, aprotinin, lima-bean trypsin inhibitor, p-tosyl-Larginine methyl ester and glucagon were ineffective (Table 3) when used in a concentration range that is known to inhibit insulin degradation in other cell systems.
The effects of chloroquine and bacitracin on the time course of binding of 125 I-labelled insulin and degradation of cell-associated radioactivity were also examined. The inhibitory effect of these drugs on insulin degradation occurred as soon as this process could be detected, i.e. after 4 min. It was more pronounced during the phase of insulin association than at the steady-state (Fig. 2) . In contrast, no increase in total cell-associated radioactivity was detectable before 20 min. Later on this effect became more important, as a result of a slow but progressive increase in cell-associated radioactivity in the presence of the drugs. For example, the presence of 46,uM-chloroquine for 2-6h increased the cellassociated radioactivity by more than 3-fold compared with control values (Table 2 ). In addition to
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Time of extraction (h) 0 2 4 6 2 4 6 2* 2* Table 3 . Effect ofdifferent agents on the binding and degradation of '251-labelled insulin Hepatocytes were incubated at 37°C for 20min with 3 nM-'251-labelled insulin. The agents tested were added together with 125I-labelled insulin at the concentrations indicated. At the end of incubation, the total amount and the percentage of trichloroacetic acid-soluble radioactivity in the cell extracts were determined as described in the Materials and methods section. Each culture represents 1.2 x 106, 1.4 x106 and 1.3 x 106 18-day-foetal hepatocytes in 2ml of culture medium for Expts. 1, 2, and 3 respectively. None of the agents listed in the affecting binding and degradation of 125I-labelled insulin, chloroquine decreased the rate at which cell-associated radioactivity was released into the medium, after removal of extracellular hormone (results not shown). Chloroquine and bacitracin also inhibited the degradation of insulin in the medium that occurred in the presence of cells. As this process is slow even in the absence of inhibitors, such effects were only detectable after 1 h. From 2 to 6 h after addition of 125I-labelled insulin, the rate of insulin degradation in the medium was inhibited by 60% in the presence of 46 gM-chloroquine (Table 2) . Effects of inhibitors of insulin degradation on basal and insulin-stimulated glycogenesis Chloroquine, bacitracin and NH4Cl were first examined for their effect on basal glycogenesis. In these experiments, [4C]glucose incorporation into glycogen was measured over a 2h incubation period in the absence of insulin, and each drug was tested at concentrations that inhibited insulin degradation maximally. Basal glycogenesis was in general not affected by chloroquine concentrations below or equal to 100gUM (Fig. 3) on the ability of insulin to stimulate glycogenesis. In the experiment presented in Fig. 3 , a total inhibition of the effect of 3 nM-insulin occurred with 100puM-chloroquine, and the concentration required for a half-maximal effect was about 20,uM. It is noteworthy that the same concentration range of chloroquine was effective on insulin-stimulated glycogenesis as on insulin degradation and cellassociated radioactivity (Fig. 3) . For 2 mMbacitracin, the stimulation index in the presence of 3 nM-insulin was also decreased, from 3.1 in control cultures to 1.9 in the presence of the drug. To test the possibility that chloroquine might also intervene at some other specific step of the glycogenic pathway, tests were made on its effect on the glycogenic action of a glucose load. Chloroquine concentrations that were effective in inhibiting insulin degradation again impaired the insulin effect, but did not affect the glucose-load stimulated, or the basal, glycogenesis (Table 4 ). The effect of bacitracin on the glucose-load-stimulated glycogenesis was not tested.
Discussion
The functional relationship between insulin binding and insulin degradation was examined in foetal hepatocytes in culture. Insulin degradation was observed in the culture medium as well as within the cell itself. As no insulin-degradative activity was released extracellularly, this implies that the degradation products arose solely from the cells. The process of insulin degradation described in this paper would thus appear to be exclusively receptormediated. Insulin binding and insulin degradation have also been correlated in isolated (Terris & Steiner, 1975) and cultured (Caro & Amatruda, 1980 ) adult hepatocytes, and in perfused liver (Terris & Steiner, 1976) . However, a non-receptormediated degradation has been found in other isolated hepatocyte preparations, especially at 370C (Le Cam et aL, 1975; Gammeltoft et al., 1978) . This degradation process may be due to insulin-degrading proteinases released into the medium (Gammeltoft et al., 1978) . There is evidence to show that receptormediated insulin degradation occurs intracellularly, and involves lysosomes. Internalization, and association of insulin with lysosomes or closely related structures, have been demonstrated morphologically in isolated hepatocytes (Carpentier et al., 1979b) and intact liver (Bergeron et al., 1979; Carpentier et al., 1979a) . Biochemical studies with the latter system have shown that internalized insulin, unlike insulin bound to cell-surface membranes, is, in part, degraded hormone (Desbuquois et al., 1979; Posner et al., 1980) . The presence of cell-associated degradation products in cultured foetal hepatocytes suggests a process of insulin internalization. Indeed, any product formed at the cell surface, by virtue of its inability to bind to the receptors, would not be expected to remain associated to cells.
In the present study, the lysosomotropic amine chloroquine was found to inhibit degradation of both cell-associated insulin and medium insulin, and concomitantly to increase cell-associated radioactivity. NH4Cl and lidocaine produced similar effects, whereas leupeptin was ineffective; these results confirm those obtained with adult hepatocytes and hepatoma cells (Terris et al., 1979) . The enhanced binding caused by chloroquine presumably reflects the accumulation of undegraded insulin within the cell, rather than an increase in the number and/or the affinity of the receptors (Marshall & Vol. 202 Olefsky, 1979) . Lysosomotropic amines are generally believed to inhibit lysosomal proteolysis by their ability to increase lysosomal pH; they may also directly affect the activity of some lysosomal proteinases, like cathepsin B, (De Duve et al., 1974) .
Chloroquine has been found to enhance the association of insulin to adipocytes (Hammons & Jarett, 1980) and of epidermal growth factor to fibroblasts (McKanna et al., 1979) ; in both cases, morphologically identified lysosomes were involved. These findings do not rule out the possibility that chloroquine may also interfere with earlier steps in the processing of receptor-bound ligands.
In cultured foetal hepatocytes, the polypeptide antibiotic bacitracin was found to modify insulin binding and degradation in the same way as chloroquine. Bacitracin is known to inhibit insulin and glucagon degradation in broken and intact liver cell preparations (Desbuquois et al., 1974; Carpentier et al., 1979b; Rouer et al., 1980) , as well as liver glutathione-insulin transhydrogenase lproteindisulphide reductase (glutathione); Roth, 1981] . This drug, and dansylcadaverine, which is also an effective inhibitor of insulin degradation in the present study, have been reported to block epidermal growth factor receptor-mediated endocytosis, and to inhibit transglutaminase (Maxfield et al., 1979; Haigler et al., 1980) . However, as bacitracin has been shown to enhance binding, and to inhibit degradation of glucagon in liver membranes (Desbuquois et al., 1974) , it is not certain that this drug acts at intracellular sites. Furthermore, bacitracin is not known to accumulate in lysosomes and/or to inhibit lysosomal enzymes. It is of interest to note that bacitracin, which inhibits non-receptormediated insulin degradation in isolated adult hepatocytes (Carpentier et al., 1979b; Rouer et al., 1980) is also an effective inhibitor of the receptormediated process in cultured foetal hepatocytes.
Polypeptides that were chemically unrelated to insulin, several inhibitors of trypsin or related enzymes and N-ethylmaleimide failed to inhibit insulin cellular degradation in the present study. Since some of these agents can inhibit insulin degradation by liver membranes (Freychet et al., 1972) and purified proteolytic enzymes (Burghen et al., 1972; Varandani et al., 1975) , their effectiveness in foetal hepatocytes may be due to their inability to have access to the insulin-inactivating system(s).
When these inhibitors block insulin degradation in isolated hepatocytes (Le Cam et al., 1975; Carpentier et al., 1979b) and circulating granulocytes (Fussanger et al., 1976) , they may do so by acting on non-receptor-mediated degradation processes. The effects of the inhibitors described here do not provide further information on the nature of the enzyme(s) involved in cell-associated insulin degradation in hepatocytes. Two potential candidates are the enzymes glutathione-insulin transhydrogenase (Varandani et al., 1975) and insulin-specific proteinase (Burghen et al., 1972) . Although these enzymes are not primarily associated with lysosomes, both have been identified in liver membranes (Varandani, 1973; Duckworth, 1979) ; this finding is consistent with the suggestion (Terris et al., 1979) that an early degradative event may affect insulin at the cell surface before, or during, endocytosis of the ligand-receptor complex.
One major finding of the present study was that chloroquine and bacitracin can inhibit insulin-stimulated glycogenesis. It is noteworthy that their effect on insulin degradation and hormonal action occurred with the same concentration range of the drug. The effect of chloroquine cannot be attributed to its toxicity since both basal and glucose-stimulated glycogenesis remained unaffected. Bacitracin, which has itself a glycogenic effect, was not tested for its interference with the glycogenic effect of a glucose load. While this investigation was in progress, a report by Hofmann et al. (1980) appeared, which described a partial inhibition of both insulin-stimulated glycogenesis and insulin degradation by chloroquine, and also by vinblastine, in cultured hepatoma cells. By contrast, no relationship could be established between the inhibition of insulin degradation by chloroquine, and such short-term biological insulin effects as stimulation of glucose transport and oxidation, and inhibition of adrenaline-stimulated lipolysis in isolated adipocytes (Suzuki & Kono, 1979; Hammons & Jarett, 1980; Marshall & Olefsky, 1980) . Whether these results reflect differences in fundamental mechanisms by which insulin elicits its various effects is as yet unknown.
At first sight, the ability of chloroquine and bacitracin to inhibit insulin degradation and insulinstimulated glycogenesis support the previous proposal (Steiner, 1977) that insulin fragments released intracellularly might mediate some effects of the hormone. Several observations are consistent with this proposal; synthetic peptides with the sequence B22-B26 have insulin-like action (Weitzel et al., 1975) , antibodies against glutathione-insulin transhydrogenase suppress phosphodiesterase activation by insulin in isolated adipocytes (Phelps & Varandani, 1977) and IM9 lymphocytes, which failed to show biological responsiveness to insulin, do not degrade receptor-bound insulin (Sonne & Gliemann, 1980) . However, because anti-(insulin receptor) antibodies mimic short-term (Kahn et al., 1977) and long-term (Van Obberghen et al., 1979) effects of insulin, this mechanism is now regarded as unlikely. For example, anti-(insulin receptor) antibodies have been shown to both mimic the glycogenic effect of insulin as well as to inhibit insulin binding in isolated preparations of muscle (Le Marchand-Brustel et al., 1978) and adult hepatocytes (Baldwin et al., 1980) . The results presented here, and those of Hofmann et al. (1980) , are compatible with the concept that degradation of a cellular, perhaps membrane-associated, component may be involved in insulin action. It is significant that insulin has been shown to trigger the proteolytic release of a peptide material in isolated adipocyte membranes that activates pyruvate dehydrogenase (Seals & Czech, 1980; Seals & Jarett, 1980) . This material may be identical with the chemical mediator generated by insulin in muscle (Lamer et al., 1979; Jarett & Seals, 1979) .
In this context, the relationship between insulin degradation and its glycogenic effect in cultured foetal hepatocytes could be explained if we postulate that insulin degradation, and the proteolytic process implied in the generation of the chemical mediator of insulin, are functionally related, or just correlated. An alternative possibility would be that the insulin-degrading activity, by liberating the insulin receptor, could modify the fate of the receptor in the cell, thus influencing the number, and the rate of renewal, of insulin receptors at the cell surface.
